Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation

Annals of Thoracic Surgery

Volumn 67, Issue 4, 1999, Pages 1006-1011

  Chancy, Mark A ^a   Nikolov, Mihail P ^a   Blakeman, Bradford P ^a   Bakhos, Mamdouh ^a   Slogoff, Stephen ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; PLACEBO;

ADULT; AGED; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; EXTUBATION; FEMALE; HEART SURGERY; HEMODYNAMICS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; VASODILATATION;

ADULT; AGED; COMPLEMENT ACTIVATION; COMPLEMENT C3A; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HEMODYNAMIC PROCESSES; HUMANS; INTUBATION, INTRATRACHEAL; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES; VASCULAR RESISTANCE;

EID: 0032915118     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)00067-3     Document Type: Article

References (24)

1. Engelman R.M., Rousou J.A., Flack J.E., Deaton D.W., Kalfin R., Das D.K. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass. Ann Thorac Surg. 60:1995;801-804.
2. Anderson L.W., Baek L., Thomsen B.S., Rasmussen J.P. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery. J Cardiothorac Anesth. 3:1989;544-549.
3. Cavarocchi N.C., Pluth J.R., Schaff H.V., et al. Complement activation during cardiopulmonary bypass; comparison of bubble and membrane oxygenators. J Thorac Cardiovasc Surg. 91:1986;252-258.
4. Van Overveld F.J., De Jongh R.F., Jorens P.G., Walter P., Bossaert L., De Backer W.A. Pretreatment with methylprednisolone in coronary artery bypass grafting influences the levels of histamine and tryptase in serum but not in bronchoalveolar lavage fluid. Clin Sci. 86:1994;49-53.
5. Jorens P.G., De Jongh R., De Backer W., et al. Interleukin-8 production in patients undergoing cardiopulmonary bypass; the influence of pretreatment with methylprednisolone. Am Rev Respir Dis. 148:1993;890-895.
6. Jansen N.J.G., van Oeveren W., van Vliet M., Stoutenbeek C.P., Eysman L., Wildevuur C.R.H. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass. Eur J Cardiothorac Surg. 5:1991;211-217.
7. Fosse E., Mollnes T.E., Osterud A., Aasen A.O. Effects of methylprednisolone on complement activation and leukocyte counts during cardiopulmonary bypass. Scand J Thorac Cardiovasc Surg. 21:1987;255-261.
8. Tennenberg S.D., Bailey W.W., Cotta L.A., Brodt J.K., Solomkin J.S. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass. Surgery. 100:1986;134-142.
9. Boscoe M.J., Yewdall V.M.A., Thompson M.A., Cameron J.S. Complement activation during cardiopulmonary bypass quantitative study of effects of methylprednisolone and pulsatile flow . Br Med J. 287:1983;1747-1750.
10. Niazi Z., Flodin P., Joyce L., Smith J., Mauer H., Lillehei R.C. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery. Chest. 76:1979;262-268.
11. Rao G., King J., Ford W., King G. The effects of methylprednisolone on the complications of coronary artery surgery. Vasc Surg. 11:1977;1-7.
12. Dietzman R.H., Lunseth J.B., Goott B., Berger E.C. The use of methylprednisolone during cardiopulmonary bypass; a review of 427 cases. J Thorac Cardiovasc Surg. 69:1975;870-873.
13. Dietzman R.H., Castaneda A.R., Lillehei C.W., Ersek R.A., Motsay G.J., Lillehei R.C. Corticosteroids as effective vasodilators in the treatment of low output syndrome. Chest. 57:1970;440-453.
14. Moses M.L., Camishion R.C., Tokunaga K., Pierucci L., Davies A.L., Nealon T.F. Effect of corticosteroid on the acidosis of prolonged cardiopulmonary bypass. J Surg Res. 6:1966;354-360.
15. Teoh K.H.T., Bradley C.A., Gauldie J., Burrows H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation. 92:(suppl 2):1995;347-353.
16. Thompson M.A., Broadbent M.P. Methylprednisolone prior to cardiopulmonary bypass. Anaesthesia. 35:1980;345-353.
17. Toledo-Pereyra L.H., Lin C.Y., Kundler H., Replogle R.L. Steroids in heart surgery a clinical double-blind and randomized study . Am Surg. 46:1980;155-160.
18. Coffin L.H., Shinozaki T., DeMeules J.E., Browdle D.A., Deane R.S.D., Morgan J.G. Ineffectiveness of methylprednisolone in the treatment of pulmonary dysfunction after cardiopulmonary bypass. Am J Surg. 130:1975;555-559.
19. Borsos T., Rapp H.J. Complement fixation on cell surfaces by 19S and 7S antibodies. Science. 150:1965;505-506.
20. Kirklin J.K., Westaby S., Blackstone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 86:1983;845-857.
21. Seghaye M.C., Duchateau J., Grabitz R.G., et al. Complement activation during cardiopulmonary bypass in infants and children; relation to postoperative multiple system organ failure. J Thorac Cardiovasc Surg. 106:1993;978-987.
22. Journois D., Israel-Biet D., Pouard P., et al. High-volume zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology. 85:1996;965-976.
23. Journois D., Pouard P., Greeley W.J., Mauriat P., Vouhé P., Safran D. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery; effects on hemostasis, cytokines, and complement components. Anesthesiology. 81:1994;1181-1189.
24. Chaney M.A., Nikolov M.P., Blakeman B., Bakhos M., Slogoff S. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation. Anesth Analg. 87:1998;27-33.